COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,627 Articles (22,913 medRxiv, 8,714 bioRxiv)

Most recent first Previous |  Page 736: Articles 7351-7360  | Next

A simple SEIR-V model to estimate COVID-19 prevalence and predict SARS-CoV-2 transmission using wastewater-based surveillance data
Phan, T., Brozak, S., Pell, B., Gitter, A., Mena, K. D., Kuang, Y., Wu, F.
10.1101/2022.07.17.22277721 — Posted: 2022-07-18
Ad26.COV2.S priming provides a solid immunological base for mRNA-based COVID-19 booster vaccination
Geers, D., Sablerolles, R., van Baarle, D., Kootstra, N., Rietdijk, W., Schmitz, K., Bogers, S., Gommers, L., Nieuwkoop, N., van Dijk, L., van Haren, E., Lafeber, M., Dalm, V. A. S. H., Goorhuis, B., Postma, D., Visser, L., Huckriede, A., Sette, A., Grifoni, A., de Swart, R., Koopmans, M., van der Kuy, H., GeurtsvanKessel, C., de Vries, R. D.
10.1101/2022.07.15.22277639 — Posted: 2022-07-18
Slow waning of antibodies following a third dose of BNT162b2 in adults who had previously received two doses of inactivated vaccine
Cowling, B. J., Cheng, S. M. S., Martin-Sanchez, M., Au, N., Chan, K. C. K., Li, J. K. C., Luk, L. L. H., Tsang, L. C. H., Ip, D. K. M., Poon, L. L. M., Leung, G. M., Peiris, M., Leung, N. H. L.
10.1101/2022.07.18.22277741 — Posted: 2022-07-18
A pilot surveillance report of SARS-CoV-2 rapid antigen test results among volunteers in Germany, 1st week of July 2022
Stemler, J., Salmanton-Garcia, J., Weise, B., Toebben, C., Joisten, C., Fleig, J., Cornely, O. A., VACCELERATE Consortium
10.1101/2022.07.18.22277744 — Posted: 2022-07-18
The association of typical and atypical symptoms on in-hospital mortality of older adults with COVID-19: a multicentre cohort study
Wong, E. K.-C., Watt, J., Zou, H., Chandraraj, A., Zhang, A. W., Brookes, J., Verduyn, A., Berall, A., Norman, R., Piggott, K. L., Izukawa, T., Straus, S. E., Liu, B.
10.1101/2022.07.16.22277716 — Posted: 2022-07-18
Drivers and prevalence of COVID-19 vaccine uptake among homeless and precariously housed people in France: a cross-sectional population-based study
ROEDERER, T., MOLLO, B., VINCENT, C., LEDUC, G., SAYYAD, J., MOSNIER, M., VANDENTORREN, S.
10.1101/2022.07.18.22276918 — Posted: 2022-07-18
COVID-19 Vaccine Booster Dose Willingness Among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional Study
Shehab, M., Alrashed, F., Alfadhli, A.
10.1101/2022.07.18.22277757 — Posted: 2022-07-18
Pandemic modelling for regions implementing an elimination strategy
Hurford, A., Martignoni, M. M., Loredo-Osti, J. C., Anokye, F., Arino, J., Husain, B. S., Gaas, B., Watmough, J.
10.1101/2022.07.18.22277695 — Posted: 2022-07-18
The Impact of Schools on the Transmission of Sars-Cov-2: Evidence from Italy
Lattanzio, S.
10.1101/2022.07.18.22276940 — Posted: 2022-07-18
Loss of SARS-CoV-2 Seropositivity among Healthy Young Adults over Seven Months
Lea, S., Simeonsson, K., Kipp, A., McNeill, C., Wilcox, L., Irish, W., Morris, H., Diaz, O., Fallon, J., Roper, R. L.
10.1101/2022.07.15.22277688 — Posted: 2022-07-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).